ハイドロキシアパタイト市場レポート：タイプ、用途、地域別、2025年～2033年

ハイドロキシアパタイトの世界市場規模は2024年に27億2,000万米ドルに達しました。今後、IMARC Groupは、市場は2033年までに42億2,000万米ドルに達し、2025年から2033年にかけて4.94%の成長率（CAGR）を示すと予測しています。医療用途における進歩の拡大、身体の自然治癒手順を刺激する再生医療への注目の高まり、生体適合性を高めるための金属インプラントにおけるハイドロキシアパタイトコーティングの利用増加などが、市場を推進する主な要因の一部です。

ハイドロキシアパタイトは、脊椎動物の骨や歯の無機部分の主要物質として使用される天然由来のミネラルを指します。リン酸カルシウムの一種であり、研究所で生産することができます。天然、合成、ナノ結晶ハイドロキシアパタイトがあり、結晶サイズが極めて小さいため表面積が大きいのが特徴です。生体活性が高いため、ドラッグデリバリーシステムや組織工学に利用されています。また、歯のエナメル質の再石灰化と修復を促進するため、歯磨き粉や歯の詰め物にも使用されています。

ハイドロキシアパタイト市場傾向／促進要因：

バイオメディカル用途の進展

バイオメディカル用途の進歩はハイドロキシアパタイト市場にプラスの影響を与えています。ハイドロキシアパタイトは、新しい骨組織の成長をサポートする足場材料として機能する骨組織工学に広く使用されています。この分野の開発により、骨の自然な構造を模倣できる、より洗練された効果的な骨足場が開発され、より優れた組織再生が促進されつつあります。整形外科用インプラントのハイドロキシアパタイト・コーティングは、オッセオインテグレーションを強化し、インプラントの不具合リスクを低減し、患者の予後を向上させる。さらに、医学研究者が整形外科分野で技術革新を続けているため、ハイドロキシアパタイトコーティングを施したインプラントの需要が高まっています。

再生医療への注目の高まり

再生医療への注目の高まりは、ハイドロキシアパタイト市場の成長にプラスの影響を与えています。再生医療は、損傷した組織や臓器を再生または修復するために、身体の自然治癒手順を刺激する治療法や技術の開発に焦点を当てています。ハイドロキシアパタイトは、新しい組織の成長に生体適合性のある足場を提供するため、この分野における重要な材料です。ハイドロキシアパタイトは、骨組織の再生を促進するために骨移植片やインプラントに使用することができ、再生医療アプローチにおいて不可欠な要素となっています。さらに、再生医療アプローチでは、組織再生をサポートするインプラントの開発にバイオマテリアルを使用することが多いです。さらに、ハイドロキシアパタイトコーティングを施したインプラントは、周囲の骨組織との一体化を促進し、インプラントの拒絶反応や破損のリスクを低下させる。これは、関節置換術やその他のインプラントが一般的である整形外科において特に関連性が高いです。

3Dプリンティングの普及

ヘルスケア分野における3Dプリンティングの利用拡大が、ハイドロキシアパタイト市場にプラスの影響を与えています。ハイドロキシアパタイトは生体活性セラミック材料であり、医療用途、特に骨組織工学や整形外科インプラントに広く使用されています。また、3Dプリンティングでは、複雑な形状や構造を精密かつカスタマイズして製造することができます。これは、患者固有のインプラントや足場が必要な医療用途で特に有益です。3Dプリンティングのラピッドプロトタイピング機能により、研究者やメーカーは設計を迅速に反復することができます。これにより、新しいハイドロキシアパタイトベースの製品の研究開発が加速され、医療技術の進歩と患者ケアの向上につながります。

本レポートで扱う主な質問

• 2024年の世界のハイドロキシアパタイト市場の市場規模は？
• 2025-2033年におけるハイドロキシアパタイト市場の世界市場成長率は？
• 世界のハイドロキシアパタイト市場を牽引する主要因は何か？
• 世界のハイドロキシアパタイト市場に対するCOVID-19の影響は？
• 世界のハイドロキシアパタイト市場のタイプ別内訳は？
• 世界のハイドロキシアパタイト市場の用途別内訳は？
• 世界のハイドロキシアパタイト市場における主要地域は？
• 世界のハイドロキシアパタイト市場における主要プレイヤー／企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

• 調査の目的
• ステークホルダー
• データソース
  • 一次情報
  • 二次情報
• 市場推定
  • ボトムアップアプローチ
  • トップダウンアプローチ
• 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

• 概要
• 主要業界動向

第5章 世界のハイドロキシアパタイト市場

• 市場概要
• 市場実績
• COVID-19の影響
• 市場予測

第6章 市場内訳：タイプ別

• ナノサイズ
• マイクロサイズ
• マイクロメートル以上

第7章 市場内訳：用途別

• 整形外科
• 歯科ケア
• 形成外科
• その他

第8章 市場内訳：地域別

• 北米
  • 米国
  • カナダ
• アジア太平洋地域
  • 中国
  • 日本
  • インド
  • 韓国
  • オーストラリア
  • インドネシア
  • その他
• 欧州
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン
  • ロシア
  • その他
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • その他
• 中東・アフリカ
  • 市場内訳：国別

第9章 SWOT分析

• 概要
• 強み
• 弱み
• 機会
• 脅威

第10章 バリューチェーン分析

第11章 ポーターのファイブフォース分析

• 概要
• 買い手の交渉力
• 供給企業の交渉力
• 競合の程度
• 新規参入業者の脅威
• 代替品の脅威

第12章 価格分析

第13章 競合情勢

• 市場構造
• 主要企業
• 主要企業のプロファイル
  • APS Materials Inc.
  • Berkeley Advanced Biomaterials
  • Bio-Rad Laboratories Inc.
  • CAM Bioceramics B.V.
  • Cgbio
  • Fluidinova S.A.
  • HOYA Technosurgical Corporation（Hoya Corporation）
  • Medtronic plc
  • Merz Pharma GmbH & Co. KGaA
  • SigmaGraft Biomaterials
  • SofSera Corporation
  • Taihei Chemical Industrial Co. Ltd.
  • Zimmer Biomet

List of Figures

• Figure 1: Global: Hydroxyapatite Market: Major Drivers and Challenges
• Figure 2: Global: Hydroxyapatite Market: Sales Value (in Billion USD), 2019-2024
• Figure 3: Global: Hydroxyapatite Market Forecast: Sales Value (in Billion USD), 2025-2033
• Figure 4: Global: Hydroxyapatite Market: Breakup by Type (in %), 2024
• Figure 5: Global: Hydroxyapatite Market: Breakup by Application (in %), 2024
• Figure 6: Global: Hydroxyapatite Market: Breakup by Region (in %), 2024
• Figure 7: Global: Hydroxyapatite (Nano-sized) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 8: Global: Hydroxyapatite (Nano-sized) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 9: Global: Hydroxyapatite (Micro-sized) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 10: Global: Hydroxyapatite (Micro-sized) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 11: Global: Hydroxyapatite (Greater than Micrometer) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 12: Global: Hydroxyapatite (Greater than Micrometer) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 13: Global: Hydroxyapatite (Orthopedic) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 14: Global: Hydroxyapatite (Orthopedic) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 15: Global: Hydroxyapatite (Dental Care) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 16: Global: Hydroxyapatite (Dental Care) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 17: Global: Hydroxyapatite (Plastic Surgery) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 18: Global: Hydroxyapatite (Plastic Surgery) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 19: Global: Hydroxyapatite (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 20: Global: Hydroxyapatite (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 21: North America: Hydroxyapatite Market: Sales Value (in Million USD), 2019 & 2024
• Figure 22: North America: Hydroxyapatite Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 23: United States: Hydroxyapatite Market: Sales Value (in Million USD), 2019 & 2024
• Figure 24: United States: Hydroxyapatite Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 25: Canada: Hydroxyapatite Market: Sales Value (in Million USD), 2019 & 2024
• Figure 26: Canada: Hydroxyapatite Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 27: Asia-Pacific: Hydroxyapatite Market: Sales Value (in Million USD), 2019 & 2024
• Figure 28: Asia-Pacific: Hydroxyapatite Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 29: China: Hydroxyapatite Market: Sales Value (in Million USD), 2019 & 2024
• Figure 30: China: Hydroxyapatite Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 31: Japan: Hydroxyapatite Market: Sales Value (in Million USD), 2019 & 2024
• Figure 32: Japan: Hydroxyapatite Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 33: India: Hydroxyapatite Market: Sales Value (in Million USD), 2019 & 2024
• Figure 34: India: Hydroxyapatite Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 35: South Korea: Hydroxyapatite Market: Sales Value (in Million USD), 2019 & 2024
• Figure 36: South Korea: Hydroxyapatite Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 37: Australia: Hydroxyapatite Market: Sales Value (in Million USD), 2019 & 2024
• Figure 38: Australia: Hydroxyapatite Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 39: Indonesia: Hydroxyapatite Market: Sales Value (in Million USD), 2019 & 2024
• Figure 40: Indonesia: Hydroxyapatite Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 41: Others: Hydroxyapatite Market: Sales Value (in Million USD), 2019 & 2024
• Figure 42: Others: Hydroxyapatite Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 43: Europe: Hydroxyapatite Market: Sales Value (in Million USD), 2019 & 2024
• Figure 44: Europe: Hydroxyapatite Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 45: Germany: Hydroxyapatite Market: Sales Value (in Million USD), 2019 & 2024
• Figure 46: Germany: Hydroxyapatite Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 47: France: Hydroxyapatite Market: Sales Value (in Million USD), 2019 & 2024
• Figure 48: France: Hydroxyapatite Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 49: United Kingdom: Hydroxyapatite Market: Sales Value (in Million USD), 2019 & 2024
• Figure 50: United Kingdom: Hydroxyapatite Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 51: Italy: Hydroxyapatite Market: Sales Value (in Million USD), 2019 & 2024
• Figure 52: Italy: Hydroxyapatite Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 53: Spain: Hydroxyapatite Market: Sales Value (in Million USD), 2019 & 2024
• Figure 54: Spain: Hydroxyapatite Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 55: Russia: Hydroxyapatite Market: Sales Value (in Million USD), 2019 & 2024
• Figure 56: Russia: Hydroxyapatite Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 57: Others: Hydroxyapatite Market: Sales Value (in Million USD), 2019 & 2024
• Figure 58: Others: Hydroxyapatite Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 59: Latin America: Hydroxyapatite Market: Sales Value (in Million USD), 2019 & 2024
• Figure 60: Latin America: Hydroxyapatite Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 61: Brazil: Hydroxyapatite Market: Sales Value (in Million USD), 2019 & 2024
• Figure 62: Brazil: Hydroxyapatite Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 63: Mexico: Hydroxyapatite Market: Sales Value (in Million USD), 2019 & 2024
• Figure 64: Mexico: Hydroxyapatite Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 65: Others: Hydroxyapatite Market: Sales Value (in Million USD), 2019 & 2024
• Figure 66: Others: Hydroxyapatite Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 67: Middle East and Africa: Hydroxyapatite Market: Sales Value (in Million USD), 2019 & 2024
• Figure 68: Middle East and Africa: Hydroxyapatite Market: Breakup by Country (in %), 2024
• Figure 69: Middle East and Africa: Hydroxyapatite Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 70: Global: Hydroxyapatite Industry: SWOT Analysis
• Figure 71: Global: Hydroxyapatite Industry: Value Chain Analysis
• Figure 72: Global: Hydroxyapatite Industry: Porter's Five Forces Analysis

List of Tables

• Table 1: Global: Hydroxyapatite Market: Key Industry Highlights, 2024 and 2033
• Table 2: Global: Hydroxyapatite Market Forecast: Breakup by Type (in Million USD), 2025-2033
• Table 3: Global: Hydroxyapatite Market Forecast: Breakup by Application (in Million USD), 2025-2033
• Table 4: Global: Hydroxyapatite Market Forecast: Breakup by Region (in Million USD), 2025-2033
• Table 5: Global: Hydroxyapatite Market: Competitive Structure
• Table 6: Global: Hydroxyapatite Market: Key Players

The global hydroxyapatite market size reached USD 2.72 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 4.22 Billion by 2033, exhibiting a growth rate (CAGR) of 4.94% during 2025-2033. The growing advancements in medical applications, rising focus on regenerative medicines that stimulate the natural healing procedures of the body, and increasing utilization of hydroxyapatite coatings on metal implants to enhance their biocompatibility are some of the major factors propelling the market.

Hydroxyapatite refers to a naturally occurring mineral that is used as the main substance of the inorganic parts of bones and teeth in vertebrates. It is a form of calcium phosphate and can be produced in laboratories. It is available as natural, synthetic, and nanocrystalline hydroxyapatite, which is characterized by extremely small crystal sizes, giving it a high surface area. It is employed in drug delivery systems and tissue engineering due to its enhanced bioactivity. It is also used in toothpaste and dental fillings to promote remineralization and repair of tooth enamel.

Hydroxyapatite Market Trends/Drivers:

Growing advancements in biomedical applications

The growing advancements in biomedical applications are positively influencing the hydroxyapatite market. Hydroxyapatite is widely used in bone tissue engineering, where it serves as a scaffold material to support the growth of new bone tissues. Advancements in this field are leading to the development of more sophisticated and effective bone scaffolds that can mimic the natural structure of bone, promoting better tissue regeneration. Hydroxyapatite coatings on orthopedic implants enhance their osseointegration, reducing the risk of implant failure and enhancing patient outcomes. Furthermore, as medical researchers continue to innovate in the field of orthopedics, the demand for hydroxyapatite-coated implants is rising.

Rising focus on regenerative medicine

The rising focus on regenerative medicine is positively influencing the growth of the hydroxyapatite market. Regenerative medicine focuses on developing therapies and techniques that stimulate the natural healing procedures of the body to regenerate or repair damaged tissues and organs. Hydroxyapatite is a key material in this field as it provides a biocompatible scaffold for the growth of new tissue. It can be used in bone grafts and implants to facilitate the regeneration of bone tissue, making it an essential component in regenerative medicine approaches. Moreover, regenerative medicine approaches often involve the use of biomaterials for the development of implants that support tissue regeneration. Furthermore, hydroxyapatite-coated implants promote better integration with surrounding bone tissue, lowering the risk of implant rejection or failure. This is especially relevant in orthopedics, where joint replacements and other implants are common.

Increasing popularity of 3D printing

The increasing usage of 3D printing in the healthcare sector is positively influencing the hydroxyapatite market. Hydroxyapatite is a bioactive ceramic material that is widely used in medical applications, particularly in bone tissue engineering and orthopedic implants. Additionally, 3D printing allows for precise and customized fabrication of complex shapes and structures. This is particularly beneficial in medical applications where patient-specific implants or scaffolds are required. The rapid prototyping capabilities of 3D printing allow researchers and manufacturers to iterate designs quickly. This can accelerate the research and development of new hydroxyapatite-based products, leading to advancements in medical technology and improved patient care.

Key Market Segmentation:

Breakup by Type:

• Nano-sized
• Micro-sized
• Greater than Micrometer

Nano-sized dominate the market

Nano-sized hydroxyapatite is a form of hydroxyapatite, which is a naturally produced mineral form of calcium apatite. Nano-sized hydroxyapatite is biocompatible and mimics the mineral component of bone. It is used in orthopedic and dental applications for bone grafts, implants, and scaffold materials to enhance bone regeneration. It is utilized in toothpaste formulations to help remineralize enamel, reduce tooth sensitivity, and prevent cavities. It can be employed as a carrier for drug delivery, allowing controxlled and targeted release of therapeutic agents. Nano-hydroxyapatite is used in cosmetic products like sunscreens and anti-aging creams to provide ultraviolet (UV) protection and improve the appearance of skin by promoting collagen synthesis.

Breakup by Application:

• Orthopedic
• Dental Care
• Plastic Surgery
• Others

Orthopedic holds the largest share in the market

Hydroxyapatite is often used as a bone graft substitute or filler material. It can be implanted into bone defects or voids to promote bone regeneration and healing. Implants used in orthopedic surgeries, such as joint replacements, can be coated with a layer of hydroxyapatite. This coating enhances the biocompatibility of the implant and encourages the formation of a strong bond between the implant and the bone of the patient. Hydroxyapatite can be used to repair various types of bone defects, including non-unions (failed bone healing), segmental defects (where a portion of the bone is missing), and cleft palate defects.

Breakup by Region:

• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa

North America exhibits a clear dominance, accounting for the largest hydroxyapatite market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America held the biggest market share due to the increasing demand for hydroxyapatite in the medical sector for making orthopedic implants, dental coating, and bone grafts. Besides this, rising advancements in healthcare to provide quality healthcare services to patients are propelling the growth of the market. In addition, the increasing research operations on understanding the potential of biomaterials in manufacturing regenerative medicine are contributing to the growth of the market. Apart from this, the rising demand for fluoride alternatives in dental care products is supporting the growth of the market.

Asia Pacific is estimated to expand further in this domain due to the increasing investment in biomedical research for drug delivery systems, tissue engineering, and as a scaffold for cell growth, which is bolstering the growth of the market.

Competitive Landscape:

Key market players are focusing on developing new and improved hydroxyapatite materials with enhanced properties, such as better biocompatibility, mechanical strength, and bioactivity. They are also expanding their product portfolios to offer a wide range of hydroxyapatite-based products, catering to different applications and customer needs. Top companies are investing in stringent quality control measures and certifications to meet regulatory standards. They are also focusing on expanding their market presence geographically by targeting emerging markets or regions with growing healthcare industries by setting up distribution networks or partnerships with local distributors. Leading companies are offering customized hydroxyapatite solutions based on specific customer requirements. They are also adopting effective marketing strategies that highlight the benefits of hydroxyapatite over other materials.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

• APS Materials Inc.
• Berkeley Advanced Biomaterials
• Bio-Rad Laboratories Inc.
• CAM Bioceramics B.V.
• Cgbio
• Fluidinova S.A.
• HOYA Technosurgical Corporation (Hoya Corporation)
• Medtronic plc
• Merz Pharma GmbH & Co. KGaA
• SigmaGraft Biomaterials
• SofSera Corporation
• Taihei Chemical Industrial Co. Ltd.
• Zimmer Biomet

Key Questions Answered in This Report

• 1.What was the size of the global hydroxyapatite market in 2024?
• 2.What is the expected growth rate of the global hydroxyapatite market during 2025-2033?
• 3.What are the key factors driving the global hydroxyapatite market?
• 4.What has been the impact of COVID-19 on the global hydroxyapatite market?
• 5.What is the breakup of the global hydroxyapatite market based on the type?
• 6. What is the breakup of the global hydroxyapatite market based on the application?
• 7.What are the key regions in the global hydroxyapatite market?
• 8.Who are the key players/companies in the global hydroxyapatite market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Hydroxyapatite Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Type

• 6.1 Nano-sized
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Micro-sized
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Greater than Micrometer
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast

7 Market Breakup by Application

• 7.1 Orthopedic
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Dental Care
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Plastic Surgery
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Others
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast

8 Market Breakup by Region

• 8.1 North America
  • 8.1.1 United States
    • 8.1.1.1 Market Trends
    • 8.1.1.2 Market Forecast
  • 8.1.2 Canada
    • 8.1.2.1 Market Trends
    • 8.1.2.2 Market Forecast
• 8.2 Asia-Pacific
  • 8.2.1 China
    • 8.2.1.1 Market Trends
    • 8.2.1.2 Market Forecast
  • 8.2.2 Japan
    • 8.2.2.1 Market Trends
    • 8.2.2.2 Market Forecast
  • 8.2.3 India
    • 8.2.3.1 Market Trends
    • 8.2.3.2 Market Forecast
  • 8.2.4 South Korea
    • 8.2.4.1 Market Trends
    • 8.2.4.2 Market Forecast
  • 8.2.5 Australia
    • 8.2.5.1 Market Trends
    • 8.2.5.2 Market Forecast
  • 8.2.6 Indonesia
    • 8.2.6.1 Market Trends
    • 8.2.6.2 Market Forecast
  • 8.2.7 Others
    • 8.2.7.1 Market Trends
    • 8.2.7.2 Market Forecast
• 8.3 Europe
  • 8.3.1 Germany
    • 8.3.1.1 Market Trends
    • 8.3.1.2 Market Forecast
  • 8.3.2 France
    • 8.3.2.1 Market Trends
    • 8.3.2.2 Market Forecast
  • 8.3.3 United Kingdom
    • 8.3.3.1 Market Trends
    • 8.3.3.2 Market Forecast
  • 8.3.4 Italy
    • 8.3.4.1 Market Trends
    • 8.3.4.2 Market Forecast
  • 8.3.5 Spain
    • 8.3.5.1 Market Trends
    • 8.3.5.2 Market Forecast
  • 8.3.6 Russia
    • 8.3.6.1 Market Trends
    • 8.3.6.2 Market Forecast
  • 8.3.7 Others
    • 8.3.7.1 Market Trends
    • 8.3.7.2 Market Forecast
• 8.4 Latin America
  • 8.4.1 Brazil
    • 8.4.1.1 Market Trends
    • 8.4.1.2 Market Forecast
  • 8.4.2 Mexico
    • 8.4.2.1 Market Trends
    • 8.4.2.2 Market Forecast
  • 8.4.3 Others
    • 8.4.3.1 Market Trends
    • 8.4.3.2 Market Forecast
• 8.5 Middle East and Africa
  • 8.5.1 Market Trends
  • 8.5.2 Market Breakup by Country
  • 8.5.3 Market Forecast

9 SWOT Analysis

• 9.1 Overview
• 9.2 Strengths
• 9.3 Weaknesses
• 9.4 Opportunities
• 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

• 11.1 Overview
• 11.2 Bargaining Power of Buyers
• 11.3 Bargaining Power of Suppliers
• 11.4 Degree of Competition
• 11.5 Threat of New Entrants
• 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

• 13.1 Market Structure
• 13.2 Key Players
• 13.3 Profiles of Key Players
  • 13.3.1 APS Materials Inc.
    • 13.3.1.1 Company Overview
    • 13.3.1.2 Product Portfolio
  • 13.3.2 Berkeley Advanced Biomaterials
    • 13.3.2.1 Company Overview
    • 13.3.2.2 Product Portfolio
  • 13.3.3 Bio-Rad Laboratories Inc.
    • 13.3.3.1 Company Overview
    • 13.3.3.2 Product Portfolio
    • 13.3.3.3 Financials
    • 13.3.3.4 SWOT Analysis
  • 13.3.4 CAM Bioceramics B.V.
    • 13.3.4.1 Company Overview
    • 13.3.4.2 Product Portfolio
  • 13.3.5 Cgbio
    • 13.3.5.1 Company Overview
    • 13.3.5.2 Product Portfolio
  • 13.3.6 Fluidinova S.A.
    • 13.3.6.1 Company Overview
    • 13.3.6.2 Product Portfolio
  • 13.3.7 HOYA Technosurgical Corporation (Hoya Corporation)
    • 13.3.7.1 Company Overview
    • 13.3.7.2 Product Portfolio
  • 13.3.8 Medtronic plc
    • 13.3.8.1 Company Overview
    • 13.3.8.2 Product Portfolio
    • 13.3.8.3 Financials
    • 13.3.8.4 SWOT Analysis
  • 13.3.9 Merz Pharma GmbH & Co. KGaA
    • 13.3.9.1 Company Overview
    • 13.3.9.2 Product Portfolio
  • 13.3.10 SigmaGraft Biomaterials
    • 13.3.10.1 Company Overview
    • 13.3.10.2 Product Portfolio
  • 13.3.11 SofSera Corporation
    • 13.3.11.1 Company Overview
    • 13.3.11.2 Product Portfolio
  • 13.3.12 Taihei Chemical Industrial Co. Ltd.
    • 13.3.12.1 Company Overview
    • 13.3.12.2 Product Portfolio
  • 13.3.13 Zimmer Biomet
    • 13.3.13.1 Company Overview
    • 13.3.13.2 Product Portfolio
    • 13.3.13.3 Financials
    • 13.3.13.4 SWOT Analysis